2014
DOI: 10.4172/2380-9477.1000105
|View full text |Cite
|
Sign up to set email alerts
|

Release Kinetics of Cellulosic Nano particulate Formulation for Oral Administration of an Antiviral Drug: Effect of Process and Formulation variables

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…In conventional drug delivery system, administration of ACV is required five times a day which results in undesirable side effects associated with high dose (Gandhi et al, 2014). Furthermore, the present marketed formulations are related to variety of disadvantages after oral administration (Naik et al, 2014). The adsorption of ACV from gastrointestinal tract is carrier mediated, so elevation of dose of ACV has caused saturation of carrier system, dose related side effects and reduced bioavailability (Malik et al, 2017a,b).…”
Section: Introductionmentioning
confidence: 99%
“…In conventional drug delivery system, administration of ACV is required five times a day which results in undesirable side effects associated with high dose (Gandhi et al, 2014). Furthermore, the present marketed formulations are related to variety of disadvantages after oral administration (Naik et al, 2014). The adsorption of ACV from gastrointestinal tract is carrier mediated, so elevation of dose of ACV has caused saturation of carrier system, dose related side effects and reduced bioavailability (Malik et al, 2017a,b).…”
Section: Introductionmentioning
confidence: 99%